Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 24 Colorectal Neoplasms 16 Small Cell Lung Carcinoma 6 Stomach Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Biliary Tract Neoplasms 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Wilms Tumor 1 Weight Loss 1 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor Cancer 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1

Interventions

Gemcitabine 11 Albumin-Bound Paclitaxel 7 Taxes 5 130-nm albumin-bound paclitaxel 4 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Fluorouracil 3 dehydroftorafur 2 Oxaliplatin 2 Losartan 2 Leucovorin 2 Irinotecan 2 Cisplatin 2 niraparib 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 X-Rays 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1 Panitumumab 1 Pancreaticoduodenectomy 1 Optical Imaging 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡